RaySearch Laboratories AB (publ) announces a large order for the treatment planning system RayStation®* by Lanzhou Ion Therapy Co, LTD, a Chinese manufacturer of accelerator systems for carbon ion therapy.
Carbon ion therapy is a highly advanced radiation therapy technique that can be effective for complex tumors which are difficult to treat with conventional methods. The market for carbon ion therapy is gaining momentum in China with several facilities either under construction, or in a planning phase.
Lanzhou Ion Therapy Co, LTD (LANITH), located in the city of Lanzhou, specializes in the development and installation of medical devices using carbon ions and other heavy ions. LANITH has now chosen RayStation to ensure maximum dose precision and workflow efficiency
The order includes RayStation licenses for three new carbon ion therapy facilities in China. The full RayStation installation includes modules for both carbon ion pencil beam scanning and for conventional photon therapy planning.
Johan Löf, founder and CEO of RaySearch, says: “RaySearch’s strategy is to be at the forefront of advancements in cancer treatments and we are the clear market leader for treatment planning for carbon ion therapy worldwide. I am proud to partner with Lanzhou Ion Therapy Co, LTD to make sure that their cancer patients in China gain access to the most sophisticated and advanced technology.”
The total order value amounts to MEUR 5.6 (approximately MSEK 56), including a five-year service contract, and the execution of the order is dependent on NMPA market clearance.
This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 3:30 pm CET on December 6, 2021.